155 related articles for article (PubMed ID: 33094334)
21. Modulated Response of
Roisin L; Melloul E; Woerther PL; Royer G; Decousser JW; Guillot J; Dannaoui E; Botterel F
Front Cell Infect Microbiol; 2020; 10():574028. PubMed ID: 33123497
[No Abstract] [Full Text] [Related]
22. Antibacterial and antibiofilm activities of ceragenins against
Damar-Çelik D; Mataracı-Kara E; Savage PB; Özbek-Çelik B
J Chemother; 2021 Jul; 33(4):216-227. PubMed ID: 32985386
[TBL] [Abstract][Full Text] [Related]
23. Comparative in vitro antimicrobial activities of CSA-142 and CSA-192, second-generation ceragenins, with CSA-13 against various microorganisms.
Bozkurt Guzel C; Oyardi O; B Savage P
J Chemother; 2018; 30(6-8):332-337. PubMed ID: 30663553
[TBL] [Abstract][Full Text] [Related]
24. Antimicrobial susceptibility of non-fermenting Gram-negative pathogens isolated from cystic fibrosis patients.
Díez-Aguilar M; Ekkelenkamp M; Morosini MI; Merino I; de Dios Caballero J; Jones M; van Westreenen M; Tunney MM; Cantón R; Fluit AC
Int J Antimicrob Agents; 2019 Jan; 53(1):84-88. PubMed ID: 30240837
[TBL] [Abstract][Full Text] [Related]
25. Genotypic and Phenotypic Characterization of Stenotrophomonas maltophilia Strains from a Pediatric Tertiary Care Hospital in Serbia.
Madi H; Lukić J; Vasiljević Z; Biočanin M; Kojić M; Jovčić B; Lozo J
PLoS One; 2016; 11(10):e0165660. PubMed ID: 27798695
[TBL] [Abstract][Full Text] [Related]
26.
Alcaraz E; Centrón D; Camicia G; Quiroga MP; Di Conza J; Passerini de Rossi B
J Med Microbiol; 2021 Jan; 70(1):. PubMed ID: 33258754
[No Abstract] [Full Text] [Related]
27.
Willsey GG; Eckstrom K; LaBauve AE; Hinkel LA; Schutz K; Meagher RJ; LiPuma JJ; Wargo MJ
J Bacteriol; 2019 Aug; 201(15):. PubMed ID: 31109991
[No Abstract] [Full Text] [Related]
28. Effects of Ceragenins and Antimicrobial Peptides on the A549 Cell Line and an In Vitro Co-Culture Model of A549 Cells and
Oyardi O; Savage PB; Guzel CB
Pathogens; 2022 Sep; 11(9):. PubMed ID: 36145476
[No Abstract] [Full Text] [Related]
29. Ceragenin-mediated disruption of Pseudomonas aeruginosa biofilms.
Wnorowska U; Łysik D; Piktel E; Zakrzewska M; Okła S; Lesiak A; Spałek J; Mystkowska J; Savage PB; Janmey P; Fiedoruk K; Bucki R
PLoS One; 2024; 19(2):e0298112. PubMed ID: 38346040
[TBL] [Abstract][Full Text] [Related]
30. CSA-131, a ceragenin active against colistin-resistant Acinetobacter baumannii and Pseudomonas aeruginosa clinical isolates.
Vila-Farrés X; Callarisa AE; Gu X; Savage PB; Giralt E; Vila J
Int J Antimicrob Agents; 2015 Nov; 46(5):568-71. PubMed ID: 26395218
[TBL] [Abstract][Full Text] [Related]
31. Phenotypic and Transcriptomic Analyses of Seven Clinical Stenotrophomonas maltophilia Isolates Identify a Small Set of Shared and Commonly Regulated Genes Involved in the Biofilm Lifestyle.
Alio I; Gudzuhn M; Pérez García P; Danso D; Schoelmerich MC; Mamat U; Schaible UE; Steinmann J; Yero D; Gibert I; Kohl TA; Niemann S; Gröschel MI; Haerdter J; Hackl T; Vollstedt C; Bömeke M; Egelkamp R; Daniel R; Poehlein A; Streit WR
Appl Environ Microbiol; 2020 Nov; 86(24):. PubMed ID: 33097507
[No Abstract] [Full Text] [Related]
32. Investigation of the in vitro antifungal and antibiofilm activities of ceragenins CSA-8, CSA-13, CSA-44, CSA-131, and CSA-138 against Candida species.
Bozkurt-Guzel C; Hacioglu M; Savage PB
Diagn Microbiol Infect Dis; 2018 Aug; 91(4):324-330. PubMed ID: 29680320
[TBL] [Abstract][Full Text] [Related]
33. Ceragenins exhibit bactericidal properties that are independent of the ionic strength in the environment mimicking cystic fibrosis sputum.
Skłodowski K; Suprewicz Ł; Chmielewska-Deptuła SJ; Kaliniak S; Okła S; Zakrzewska M; Minarowski Ł; Mróz R; Daniluk T; Savage PB; Fiedoruk K; Bucki R
Front Microbiol; 2023; 14():1290952. PubMed ID: 38045035
[TBL] [Abstract][Full Text] [Related]
34. Activity of Cefiderocol Alone and in Combination with Levofloxacin, Minocycline, Polymyxin B, or Trimethoprim-Sulfamethoxazole against Multidrug-Resistant Stenotrophomonas maltophilia.
Biagi M; Vialichka A; Jurkovic M; Wu T; Shajee A; Lee M; Patel S; Mendes RE; Wenzler E
Antimicrob Agents Chemother; 2020 Aug; 64(9):. PubMed ID: 32571820
[TBL] [Abstract][Full Text] [Related]
35. In vitro antibacterial and antibiofilm activities of chlorogenic acid against clinical isolates of Stenotrophomonas maltophilia including the trimethoprim/sulfamethoxazole resistant strain.
Karunanidhi A; Thomas R; van Belkum A; Neela V
Biomed Res Int; 2013; 2013():392058. PubMed ID: 23509719
[TBL] [Abstract][Full Text] [Related]
36. In vitro antimicrobial activity of ceftolozane/tazobactam against Pseudomonas aeruginosa and other non-fermenting Gram-negative bacteria in adults with cystic fibrosis.
Gramegna A; Millar BC; Blasi F; Elborn JS; Downey DG; Moore JE
J Glob Antimicrob Resist; 2018 Sep; 14():224-227. PubMed ID: 29559421
[TBL] [Abstract][Full Text] [Related]
37. Subinhibitory concentrations of moxifloxacin decrease adhesion and biofilm formation of Stenotrophomonas maltophilia from cystic fibrosis.
Pompilio A; Catavitello C; Picciani C; Confalone P; Piccolomini R; Savini V; Fiscarelli E; D'Antonio D; Di Bonaventura G
J Med Microbiol; 2010 Jan; 59(Pt 1):76-81. PubMed ID: 19762476
[TBL] [Abstract][Full Text] [Related]
38. Molecular Insight into Gene Response of Diorcinol- and Rubrolide-Treated Biofilms of the Emerging Pathogen Stenotrophomonas maltophilia.
Gudzuhn M; Alio I; Moll R; de Vries J; Boehlich J; Assmann M; Janneschütz J; Schützenmeister N; Himmelbach A; Poehlein A; Daniel R; Streit WR
Microbiol Spectr; 2022 Jun; 10(3):e0258221. PubMed ID: 35471093
[TBL] [Abstract][Full Text] [Related]
39. Optimization of ceragenins for prevention of bacterial colonization of hydrogel contact lenses.
Gu X; Jennings JD; Snarr J; Chaudhary V; Pollard JE; Savage PB
Invest Ophthalmol Vis Sci; 2013 Sep; 54(9):6217-23. PubMed ID: 23970466
[TBL] [Abstract][Full Text] [Related]
40. New β-Lactam Antibiotics and Ceragenins - A Study to Assess Their Potential in Treatment of Infections Caused by Multidrug-Resistant Strains of
Paprocka P; Durnaś B; Mańkowska A; Skłodowski K; Król G; Zakrzewska M; Czarnowski M; Kot P; Fortunka K; Góźdź S; Savage PB; Bucki R
Infect Drug Resist; 2021; 14():5681-5698. PubMed ID: 34992394
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
